208 related articles for article (PubMed ID: 33838662)
21. Combination of single-photon emission computed tomography and magnetic resonance imaging to track 111in-oxine-labeled human mesenchymal stem cells in neuroblastoma-bearing mice.
Cussó L; Mirones I; Peña-Zalbidea S; García-Vázquez V; García-Castro J; Desco M
Mol Imaging; 2014; 13():. PubMed ID: 25248941
[TBL] [Abstract][Full Text] [Related]
22. [Effect of CCR1 gene overexpression on the migration of bone marrow - derived mesenchymal stem cells towards hepatocellular carcinoma].
Gao Y; Huang XL; Zhang L; Deng L; Yin AH; Sun BC; Lu S
Zhonghua Gan Zang Bing Za Zhi; 2017 May; 25(5):354-359. PubMed ID: 28763842
[No Abstract] [Full Text] [Related]
23. A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma.
Geminder H; Sagi-Assif O; Goldberg L; Meshel T; Rechavi G; Witz IP; Ben-Baruch A
J Immunol; 2001 Oct; 167(8):4747-57. PubMed ID: 11591806
[TBL] [Abstract][Full Text] [Related]
24. Human mesenchymal stem cells overexpressing pigment epithelium-derived factor inhibit hepatocellular carcinoma in nude mice.
Gao Y; Yao A; Zhang W; Lu S; Yu Y; Deng L; Yin A; Xia Y; Sun B; Wang X
Oncogene; 2010 May; 29(19):2784-94. PubMed ID: 20190814
[TBL] [Abstract][Full Text] [Related]
25. Expression of CD44 is associated with a metastatic pattern of human neuroblastoma cells in a SCID mouse xenograft model.
Valentiner U; Valentiner FU; Schumacher U
Tumour Biol; 2008; 29(3):152-60. PubMed ID: 18612220
[TBL] [Abstract][Full Text] [Related]
26. Human mesenchymal stem cells promote tumor growth via MAPK pathway and metastasis by epithelial mesenchymal transition and integrin α5 in hepatocellular carcinoma.
Chen J; Ji T; Wu D; Jiang S; Zhao J; Lin H; Cai X
Cell Death Dis; 2019 May; 10(6):425. PubMed ID: 31142737
[TBL] [Abstract][Full Text] [Related]
27. Novel mesenchymal stem cell delivery system as targeted therapy against neuroblastoma using the TH-MYCN mouse model.
Maniwa J; Fumino S; Kimura K; Tanaka T; Higashi M; Kishida T; Mazda O; Tajiri T
J Pediatr Surg; 2019 Dec; 54(12):2600-2605. PubMed ID: 31627888
[TBL] [Abstract][Full Text] [Related]
28. Mesenchymal stromal cells primed with paclitaxel provide a new approach for cancer therapy.
Pessina A; Bonomi A; Coccè V; Invernici G; Navone S; Cavicchini L; Sisto F; Ferrari M; Viganò L; Locatelli A; Ciusani E; Cappelletti G; Cartelli D; Arnaldo C; Parati E; Marfia G; Pallini R; Falchetti ML; Alessandri G
PLoS One; 2011; 6(12):e28321. PubMed ID: 22205945
[TBL] [Abstract][Full Text] [Related]
29. The metastatic microenvironment: lung-derived factors control the viability of neuroblastoma lung metastasis.
Maman S; Edry-Botzer L; Sagi-Assif O; Meshel T; Yuan W; Lu W; Witz IP
Int J Cancer; 2013 Nov; 133(10):2296-306. PubMed ID: 23649556
[TBL] [Abstract][Full Text] [Related]
30. Activation of signal transducers and activators of transcription 3 and focal adhesion kinase by stromal cell-derived factor 1 is required for migration of human mesenchymal stem cells in response to tumor cell-conditioned medium.
Gao H; Priebe W; Glod J; Banerjee D
Stem Cells; 2009 Apr; 27(4):857-65. PubMed ID: 19350687
[TBL] [Abstract][Full Text] [Related]
31. Mesenchymal stem cells as therapeutic delivery vehicles targeting tumor stroma.
Serakinci N; Christensen R; Fahrioglu U; Sorensen FB; Dagnæs-Hansen F; Hajek M; Jensen TH; Kolvraa S; Keith NW
Cancer Biother Radiopharm; 2011 Dec; 26(6):767-73. PubMed ID: 21877908
[TBL] [Abstract][Full Text] [Related]
32. A fluorescent orthotopic mouse model for reliable measurement and genetic modulation of human neuroblastoma metastasis.
Henriksson KC; Almgren MA; Thurlow R; Varki NM; Chang CL
Clin Exp Metastasis; 2004; 21(6):563-70. PubMed ID: 15679054
[TBL] [Abstract][Full Text] [Related]
33. Establishment of a neuroblastoma mouse model by subcutaneous xenograft transplantation and its use to study metastatic neuroblastoma.
Gao Q; Chen CF; Dong Q; Hou L; Chen X; Zhi YL; Li X; Lu HT; Zhang HY
Genet Mol Res; 2015 Dec; 14(4):16297-307. PubMed ID: 26662423
[TBL] [Abstract][Full Text] [Related]
34. Transfer of malignant trait to immortalized human cells following exposure to human cancer serum.
Abdouh M; Zhou S; Arena V; Arena M; Lazaris A; Onerheim R; Metrakos P; Arena GO
J Exp Clin Cancer Res; 2014 Sep; 33(1):86. PubMed ID: 25266310
[TBL] [Abstract][Full Text] [Related]
35. The critical roles of tumor-initiating cells and the lymph node stromal microenvironment in human colorectal cancer extranodal metastasis using a unique humanized orthotopic mouse model.
Margolin DA; Myers T; Zhang X; Bertoni DM; Reuter BA; Obokhare I; Borgovan T; Grimes C; Green H; Driscoll T; Lee CG; Davis NK; Li L
FASEB J; 2015 Aug; 29(8):3571-81. PubMed ID: 25962655
[TBL] [Abstract][Full Text] [Related]
36. Purinergic stimulation of human mesenchymal stem cells potentiates their chemotactic response to CXCL12 and increases the homing capacity and production of proinflammatory cytokines.
Ferrari D; Gulinelli S; Salvestrini V; Lucchetti G; Zini R; Manfredini R; Caione L; Piacibello W; Ciciarello M; Rossi L; Idzko M; Ferrari S; Di Virgilio F; Lemoli RM
Exp Hematol; 2011 Mar; 39(3):360-74, 374.e1-5. PubMed ID: 21145936
[TBL] [Abstract][Full Text] [Related]
37. Human marrow stromal cells secrete microRNA-375-containing exosomes to regulate glioma progression.
Deng SZ; Lai MF; Li YP; Xu CH; Zhang HR; Kuang JG
Cancer Gene Ther; 2020 Apr; 27(3-4):203-215. PubMed ID: 30728448
[TBL] [Abstract][Full Text] [Related]
38. The optimal time to inject bone mesenchymal stem cells for fracture healing in a murine model.
Wang X; Wang C; Gou W; Xu X; Wang Y; Wang A; Xu W; Guo Q; Liu S; Lu Q; Meng H; Yuan M; Peng J; Lu S
Stem Cell Res Ther; 2018 Oct; 9(1):272. PubMed ID: 30359311
[TBL] [Abstract][Full Text] [Related]
39. TRAIL-secreting human mesenchymal stem cells engineered by a non-viral vector and photochemical internalization for pancreatic cancer gene therapy.
Han J; Hwang HS; Na K
Biomaterials; 2018 Nov; 182():259-268. PubMed ID: 30142525
[TBL] [Abstract][Full Text] [Related]
40. Mesenchymal stromal cell secretome up-regulates 47 kDa CXCR4 expression, and induce invasiveness in neuroblastoma cell lines.
Shankar V; Hori H; Kihira K; Lei Q; Toyoda H; Iwamoto S; Komada Y
PLoS One; 2015; 10(3):e0120069. PubMed ID: 25774696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
